Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Fadi Atrash"'
Publikováno v:
SAGE Open Medical Case Reports, Vol 12 (2024)
Colorectal cancer ranks third in cancer incidence in the United States, commonly metastasizing to the liver and lungs. Despite its high prevalence, colorectal cancer with intraocular metastasis is exceedingly rare, with only a few cases reported in t
Externí odkaz:
https://doaj.org/article/08d4c5e2af3c49fc8020cc755ce1aefe
Publikováno v:
Case Reports in Medicine, Vol 2012 (2012)
Central nervous system metastases from nasopharyngeal carcinoma (NPC) are uncommon. The patient presented was diagnosed with aggressive advanced NPC resistant to treatment and complicated by a solitary brain metastasis. A PubMed database search was c
Externí odkaz:
https://doaj.org/article/f9ce6bea91ca48c3953ffb89ff2929d6
Publikováno v:
The Lancet. Oncology. 20(11)
Publikováno v:
The Lancet Oncology. 19:869-870
Publikováno v:
The Israel Medical Association journal : IMAJ. 17(7)
Anal cancer is a relatively uncommon disease, accounting for only 4% of cancers of the lower gastrointestinal tract.To summarize a single-center experience in the treatment of anal carcinoma using various radiation techniques.We conducted a retrospec
Autor:
Salem, Billan, Orit, Kaidar-Person, Fadi, Atrash, Ilana, Doweck, Nissim, Haim, Abraham, Kuten, Ohad, Ronen
Publikováno v:
The Israel Medical Association journal : IMAJ. 15(5)
The role of induction chemotherapy in advanced squamous cell carcinoma of the head and neck (SCCHN) is under constant debate. Surgery, radiotherapy, chemotherapy, and targeted therapies are part of the treatment strategy in these patients, but their
Publikováno v:
Case Reports in Medicine
Case Reports in Medicine, Vol 2012 (2012)
Case Reports in Medicine, Vol 2012 (2012)
Central nervous system metastases from nasopharyngeal carcinoma (NPC) are uncommon. The patient presented was diagnosed with aggressive advanced NPC resistant to treatment and complicated by a solitary brain metastasis. A PubMed database search was c
Autor:
Salim Hadad, Nissim Haim, Shimon Pollack, Eduardo Shahar, Fadi Atrash, Eynat Kedem, Gil Bar-Sela
Publikováno v:
Japanese journal of clinical oncology. 40(2)
Sunitinib is an orally bioavailable small molecule that inhibits multiple receptor tyrosine kinases. Generalized hypersensitivity reactions (HSR) to sunitinib have not been described. A patient with a gastrointestinal stromal tumor (GIST) who develop